IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Ibuprofen And Phenylephrine Hydrochloride patents expire, and when can generic versions of Ibuprofen And Phenylephrine Hydrochloride launch?
Ibuprofen And Phenylephrine Hydrochloride is a drug marketed by Perrigo R And D and is included in one NDA.
The generic ingredient in IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE is ibuprofen; phenylephrine hydrochloride. There are sixty-four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ibuprofen; phenylephrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ibuprofen And Phenylephrine Hydrochloride
A generic version of IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE was approved as ibuprofen; phenylephrine hydrochloride by PERRIGO R AND D on July 3rd, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE?
- What are the global sales for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE?
- What is Average Wholesale Price for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE?
Summary for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 5 |
| Clinical Trials: | 3 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
| Pfizer | Phase 3 |
| Hospital Italiano de Buenos Aires | Phase 4 |
See all IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE clinical trials
Pharmacology for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
| Drug Class | Nonsteroidal Anti-inflammatory Drug alpha-1 Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha1-Agonists Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Perrigo R And D | IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE | ibuprofen; phenylephrine hydrochloride | TABLET;ORAL | 203200-001 | Jul 3, 2014 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
